These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 3292393)

  • 1. Perforin-dependent and -independent pathways of cytotoxicity mediated by lymphocytes.
    Young JD; Liu CC; Persechini PM; Cohn ZA
    Immunol Rev; 1988 Mar; 103():161-202. PubMed ID: 3292393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance of cytolytic lymphocytes to perforin-mediated killing. Induction of resistance correlates with increase in cytotoxicity.
    Liu CC; Jiang S; Persechini PM; Zychlinsky A; Kaufmann Y; Young JD
    J Exp Med; 1989 Jun; 169(6):2211-25. PubMed ID: 2786549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function of granule perforin and esterases in T cell-mediated reactions. Components required for delivery of molecules to target cells.
    Podack ER; Lowrey DM; Lichtenheld M; Hameed A
    Ann N Y Acad Sci; 1988; 532():292-302. PubMed ID: 2972243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular mechanisms of lymphocyte-mediated lysis of tumor cells.
    Arancia G; Malorni W; Donelli G
    Ann Ist Super Sanita; 1990; 26(3-4):369-84. PubMed ID: 2151107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perforin and its role in T lymphocyte-mediated cytolysis.
    Lowin B; Krähenbühl O; Müller C; Dupuis M; Tschopp J
    Experientia; 1992 Oct; 48(10):911-20. PubMed ID: 1426142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytotoxic molecules, perforin and serine esterase in cytotoxic T lymphocyte].
    Koizumi H
    Arerugi; 1989 Jan; 38(1):41-8. PubMed ID: 2787151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of cytolytic lymphocytes to perforin-mediated killing. Murine cytotoxic T lymphocytes and human natural killer cells do not contain functional soluble homologous restriction factor or other specific soluble protective factors.
    Jiang S; Persechini PM; Perussia B; Young JD
    J Immunol; 1989 Sep; 143(5):1453-60. PubMed ID: 2503557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of granule proteins in T-cell-mediated cytolysis.
    Krähenbühl O; Tschopp J
    Nat Immun Cell Growth Regul; 1990; 9(4):274-82. PubMed ID: 2215515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of Fas ligand in cytoplasmic granules of CD8+ cytotoxic T lymphocytes and natural killer cells: participation of Fas ligand in granule exocytosis model of cytotoxicity.
    Kojima Y; Kawasaki-Koyanagi A; Sueyoshi N; Kanai A; Yagita H; Okumura K
    Biochem Biophys Res Commun; 2002 Aug; 296(2):328-36. PubMed ID: 12163021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High activity of N-alpha-benzyloxycarbonyl-L-lysine thiobenzyl ester serine esterase and cytolytic perforin in cloned cell lines is not demonstrable in in-vivo-induced cytotoxic effector cells.
    Dennert G; Anderson CG; Prochazka G
    Proc Natl Acad Sci U S A; 1987 Jul; 84(14):5004-8. PubMed ID: 2955414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related decrement in cytotoxic T lymphocyte (CTL) activity is associated with decreased levels of mRNA encoded by two CTL-associated serine esterase genes and the perforin gene in mice.
    Bloom ET; Umehara H; Bleackley RC; Okumura K; Mostowski H; Babbitt JT
    Eur J Immunol; 1990 Oct; 20(10):2309-16. PubMed ID: 2242759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Killing by cytotoxic T cells and natural killer cells: multiple granule serine proteases as initiators of DNA fragmentation.
    Trapani JA; Smyth MJ
    Immunol Cell Biol; 1993 Jun; 71 ( Pt 3)():201-8. PubMed ID: 8349302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perforin mRNA in primary peritoneal exudate cytotoxic T lymphocytes.
    Nagler-Anderson C; Lichtenheld M; Eisen HN; Podack ER
    J Immunol; 1989 Dec; 143(11):3440-3. PubMed ID: 2584700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcellular localization of perforin and serine esterase in lymphokine-activated killer cells and cytotoxic T cells by immunogold labeling.
    Ojcius DM; Zheng LM; Sphicas EC; Zychlinsky A; Young JD
    J Immunol; 1991 Jun; 146(12):4427-32. PubMed ID: 2040805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly lytic in vivo primed cytolytic T lymphocytes devoid of lytic granules and BLT-esterase activity acquire these constituents in the presence of T cell growth factors upon blast transformation in vitro.
    Berke G; Rosen D
    J Immunol; 1988 Sep; 141(5):1429-36. PubMed ID: 3261748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ECH, an epoxycyclohexenone derivative that specifically inhibits Fas ligand-dependent apoptosis in CTL-mediated cytotoxicity.
    Mitsui T; Miyake Y; Kakeya H; Osada H; Kataoka T
    J Immunol; 2004 Mar; 172(6):3428-36. PubMed ID: 15004142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An anergic cytotoxic T lymphocyte clone exhibits granule exocytosis-mediated cytotoxicity.
    Kuwano K; Akashi A; Arai S
    Cell Immunol; 1998 May; 185(2):114-22. PubMed ID: 9636689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perforin and lymphocyte-mediated cytolysis.
    Liu CC; Persechini PM; Young JD
    Immunol Rev; 1995 Aug; 146():145-75. PubMed ID: 7493752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of lymphocyte-mediated cytolysis: functional cytolytic T cells lacking perforin and granzymes.
    Berke G; Rosen D; Ronen D
    Immunology; 1993 Jan; 78(1):105-12. PubMed ID: 8436395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
    Seki N; Brooks AD; Carter CR; Back TC; Parsoneault EM; Smyth MJ; Wiltrout RH; Sayers TJ
    J Immunol; 2002 Apr; 168(7):3484-92. PubMed ID: 11907109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.